v3.25.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Condensed Consolidated Statements of Cash Flows    
Financial Designation, Predecessor and Successor [Fixed List] Successor Predecessor
Cash flows from operating activities:    
Net loss $ (11,660) $ (13,043)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 542 587
Non-cash operating lease expense   83
Stock-based compensation 452 221
Provision for inventory impairment   41
Amortization of term loan discount   10
Loss on disposal of property and equipment   58
Change in fair value of convertible notes payable (1,617) (3,966)
Change in fair value of warrant liabilities 103 (14)
Net change in operating assets and liabilities:    
Accounts receivable, net 39 (99)
Inventory, net 756 (788)
Prepaid expenses and other current assets (10) 45
Accounts payable (1,526) 1,750
Accrued liabilities (335) 386
Accrued transaction costs   (299)
Other accrued liabilities 1,379 1,428
Operating lease liabilities 10 (84)
Net cash used in operating activities (11,867) (13,684)
Cash flows from investing activities:    
Purchases of property and equipment (345) (337)
Net cash used in investing activities (345) (337)
Cash flows from financing activities:    
Proceeds from issuance of convertible notes payable   15,500
Repayment of non-convertible term loan   (857)
Net cash provided by financing activities   14,643
Effect of foreign currency translation on cash and cash equivalents (174) 40
Net change in cash and cash equivalents (12,386) 662
Cash and cash equivalents, at beginning of period 20,586 1,383
Cash and cash equivalents, at end of period $ 8,200 2,045
Supplemental disclosure of cash flow information:    
Cash paid for interest   76
Supplemental disclosure of noncash investing and financing activities:    
Right-of-use assets obtained in exchange for lease liabilities   (216)
Lease liabilities recorded for operating lease right-of-use assets   216
Exchange preferred stock for pre-funded warrants   $ 4,332